| Anaplastic lymphoma kinase inhibition in non–small-cell lung cancer EL Kwak, YJ Bang, DR Camidge, AT Shaw, B Solomon, RG Maki, SHI Ou, ... New England Journal of Medicine 363 (18), 1693-1703, 2010 | 4626 | 2010 |
| Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors LV Sequist, BA Waltman, D Dias-Santagata, S Digumarthy, AB Turke, ... Science translational medicine 3 (75), 75ra26-75ra26, 2011 | 2753 | 2011 |
| Clinical features and outcome of patients with non–small-cell lung cancer who harbor EML4-ALK AT Shaw, BY Yeap, M Mino-Kenudson, SR Digumarthy, DB Costa, ... Journal of clinical oncology 27 (26), 4247, 2009 | 1976 | 2009 |
| ROS1 rearrangements define a unique molecular class of lung cancers K Bergethon, AT Shaw, SHI Ou, R Katayama, CM Lovly, NT McDonald, ... Journal of clinical oncology 30 (8), 863, 2012 | 1471 | 2012 |
| Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases JN Vauthey, TM Pawlik, D Ribero, TT Wu, D Zorzi, PM Hoff, HQ Xiong, ... Journal of Clinical Oncology 24 (13), 2065-2072, 2006 | 1344 | 2006 |
| International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology T Shimosegawa, ST Chari, L Frulloni, T Kamisawa, S Kawa, ... Pancreas 40 (3), 352-358, 2011 | 1204 | 2011 |
| Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers R Katayama, AT Shaw, TM Khan, M Mino-Kenudson, BJ Solomon, ... Science translational medicine 4 (120), 120ra17-120ra17, 2012 | 1112 | 2012 |
| Functional genomics reveal that the serine synthesis pathway is essential in breast cancer R Possemato, KM Marks, YD Shaul, ME Pacold, D Kim, K Birsoy, ... Nature 476 (7360), 346, 2011 | 1102 | 2011 |
| Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population SJ Rodig, M Mino-Kenudson, S Dacic, BY Yeap, A Shaw, JA Barletta, ... Clinical cancer research 15 (16), 5216-5223, 2009 | 703 | 2009 |
| EGFR-mediated reactivation of MAPK signaling contributes to insensitivity of BRAF-mutant colorectal cancers to RAF inhibition with vemurafenib RB Corcoran, H Ebi, AB Turke, EM Coffee, M Nishino, AP Cogdill, ... Cancer discovery 2 (3), 227-235, 2012 | 702 | 2012 |
| EGFR mutations and ALK rearrangements are associated with low response rates to PD-1 pathway blockade in non-small cell lung cancer (NSCLC): a retrospective analysis JF Gainor, AT Shaw, LV Sequist, X Fu, CG Azzoli, Z Piotrowska, ... Clinical cancer research, clincanres. 3101.2015, 2016 | 558 | 2016 |
| Molecular mechanisms of resistance to first-and second-generation ALK inhibitors in ALK-rearranged lung cancer JF Gainor, L Dardaei, S Yoda, L Friboulet, I Leshchiner, R Katayama, ... Cancer discovery 6 (10), 1118-1133, 2016 | 552 | 2016 |
| Patient-derived models of acquired resistance can identify effective drug combinations for cancer AS Crystal, AT Shaw, LV Sequist, L Friboulet, MJ Niederst, EL Lockerman, ... Science 346 (6216), 1480-1486, 2014 | 527 | 2014 |
| Sensitive sequencing method for KRAS mutation detection by Pyrosequencing S Ogino, T Kawasaki, M Brahmandam, L Yan, M Cantor, C Namgyal, ... The Journal of molecular diagnostics 7 (3), 413-421, 2005 | 521 | 2005 |
| mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake ÖH Yilmaz, P Katajisto, DW Lamming, Y Gültekin, KE Bauer-Rowe, ... Nature 486 (7404), 490, 2012 | 496 | 2012 |
| A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry M Mino-Kenudson, LR Chirieac, K Law, JL Hornick, N Lindeman, EJ Mark, ... Clinical Cancer Research 16 (5), 1561-1571, 2010 | 487 | 2010 |
| Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal … CG Willett, Y Boucher, DG Duda, E di Tomaso, LL Munn, RT Tong, ... Journal of clinical oncology: official journal of the American Society of …, 2005 | 460 | 2005 |
| Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection JR Rodriguez, R Salvia, S Crippa, AL Warshaw, C Bassi, M Falconi, ... Gastroenterology 133 (1), 72-79, 2007 | 450 | 2007 |
| Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients S Crippa, R Salvia, AL Warshaw, I Domínguez, C Bassi, M Falconi, ... Annals of surgery 247 (4), 571, 2008 | 432 | 2008 |
| Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy C Pfirschke, C Engblom, S Rickelt, V Cortez-Retamozo, C Garris, F Pucci, ... Immunity 44 (2), 343-354, 2016 | 425 | 2016 |
